Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histiocytosis, Langerhans-Cell | 3 | 2015 | 221 | 0.510 |
Why?
|
| Colitis | 2 | 2024 | 151 | 0.370 |
Why?
|
| Neoplasms, Second Primary | 2 | 2014 | 152 | 0.370 |
Why?
|
| Langerhans Cells | 2 | 2015 | 21 | 0.360 |
Why?
|
| Eosinophilic Esophagitis | 3 | 2016 | 75 | 0.330 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2014 | 545 | 0.290 |
Why?
|
| Cephalexin | 1 | 2006 | 7 | 0.280 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 124 | 0.270 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 202 | 0.260 |
Why?
|
| Myocarditis | 1 | 2006 | 119 | 0.250 |
Why?
|
| Drug Hypersensitivity | 1 | 2006 | 96 | 0.250 |
Why?
|
| Myofibromatosis | 1 | 2025 | 8 | 0.240 |
Why?
|
| Genetic Markers | 1 | 2007 | 604 | 0.240 |
Why?
|
| Mannose-Binding Lectins | 1 | 2004 | 24 | 0.240 |
Why?
|
| Lectins, C-Type | 1 | 2004 | 70 | 0.230 |
Why?
|
| Alcoholic Beverages | 1 | 2004 | 18 | 0.230 |
Why?
|
| Alcoholic Intoxication | 1 | 2004 | 11 | 0.230 |
Why?
|
| Antigens, Surface | 1 | 2004 | 121 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 651 | 0.210 |
Why?
|
| Testicular Neoplasms | 2 | 2017 | 132 | 0.200 |
Why?
|
| Oncostatin M Receptor beta Subunit | 1 | 2021 | 1 | 0.190 |
Why?
|
| Oncostatin M | 1 | 2021 | 6 | 0.190 |
Why?
|
| Yttrium Radioisotopes | 1 | 2020 | 18 | 0.180 |
Why?
|
| Embolization, Therapeutic | 2 | 2020 | 227 | 0.170 |
Why?
|
| Hepatoblastoma | 1 | 2020 | 179 | 0.150 |
Why?
|
| Testicular Diseases | 1 | 2017 | 12 | 0.150 |
Why?
|
| Calculi | 1 | 2017 | 15 | 0.140 |
Why?
|
| Behcet Syndrome | 1 | 2017 | 16 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 313 | 0.140 |
Why?
|
| Immunoglobulin E | 2 | 2014 | 162 | 0.130 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2016 | 13 | 0.130 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2016 | 22 | 0.130 |
Why?
|
| Child | 15 | 2021 | 24247 | 0.130 |
Why?
|
| Child, Preschool | 9 | 2020 | 13904 | 0.130 |
Why?
|
| Urinary Bladder | 2 | 2014 | 238 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 180 | 0.120 |
Why?
|
| Thymus Hyperplasia | 1 | 2015 | 1 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2396 | 0.120 |
Why?
|
| Humans | 29 | 2025 | 123180 | 0.120 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 123 | 0.120 |
Why?
|
| Thymus Gland | 1 | 2015 | 100 | 0.120 |
Why?
|
| Ganglioglioma | 1 | 2014 | 24 | 0.110 |
Why?
|
| Lipoma | 1 | 2014 | 23 | 0.110 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2014 | 30 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2014 | 103 | 0.110 |
Why?
|
| Fasciitis | 1 | 2014 | 20 | 0.110 |
Why?
|
| Fibroma | 1 | 2014 | 30 | 0.110 |
Why?
|
| Arthroscopy | 1 | 2014 | 35 | 0.110 |
Why?
|
| Rhabdoid Tumor | 1 | 2014 | 49 | 0.110 |
Why?
|
| Joint Diseases | 1 | 2014 | 33 | 0.110 |
Why?
|
| Mydriasis | 1 | 2013 | 7 | 0.110 |
Why?
|
| Basophils | 1 | 2013 | 11 | 0.110 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2013 | 28 | 0.110 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2013 | 33 | 0.110 |
Why?
|
| Cytokines | 3 | 2016 | 1284 | 0.110 |
Why?
|
| Ribonuclease III | 1 | 2014 | 89 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 2013 | 136 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 555 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 120 | 0.110 |
Why?
|
| Knee Joint | 1 | 2014 | 160 | 0.100 |
Why?
|
| Autophagy | 1 | 2016 | 390 | 0.100 |
Why?
|
| Wilms Tumor | 1 | 2014 | 113 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2014 | 213 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2014 | 130 | 0.100 |
Why?
|
| Polyradiculopathy | 1 | 2012 | 2 | 0.100 |
Why?
|
| Male | 17 | 2025 | 60173 | 0.100 |
Why?
|
| Low Back Pain | 1 | 2012 | 34 | 0.100 |
Why?
|
| Spinal Neoplasms | 1 | 2012 | 59 | 0.100 |
Why?
|
| Sarcoma | 1 | 2014 | 194 | 0.090 |
Why?
|
| Antitubercular Agents | 1 | 2013 | 246 | 0.090 |
Why?
|
| Orbital Pseudotumor | 1 | 2011 | 11 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2016 | 4494 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 639 | 0.090 |
Why?
|
| Hemangioma | 1 | 2012 | 95 | 0.090 |
Why?
|
| Colon | 1 | 2013 | 352 | 0.090 |
Why?
|
| Cellulitis | 1 | 2011 | 64 | 0.090 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 151 | 0.090 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2011 | 55 | 0.090 |
Why?
|
| Blindness | 1 | 2011 | 72 | 0.090 |
Why?
|
| Anti-HIV Agents | 1 | 2013 | 304 | 0.090 |
Why?
|
| Proteins | 1 | 2016 | 1037 | 0.090 |
Why?
|
| Phosphotransferases | 1 | 2010 | 41 | 0.090 |
Why?
|
| Teratoma | 1 | 2011 | 123 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1311 | 0.080 |
Why?
|
| Adolescent | 9 | 2017 | 19111 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2025 | 8115 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 434 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2014 | 849 | 0.080 |
Why?
|
| Infant | 6 | 2015 | 12371 | 0.080 |
Why?
|
| Frameshift Mutation | 1 | 2010 | 175 | 0.080 |
Why?
|
| Mesentery | 1 | 2009 | 28 | 0.080 |
Why?
|
| Female | 14 | 2020 | 65562 | 0.080 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 136 | 0.080 |
Why?
|
| Myeloproliferative Disorders | 1 | 2010 | 90 | 0.080 |
Why?
|
| Peritoneal Neoplasms | 1 | 2009 | 28 | 0.080 |
Why?
|
| Intestinal Volvulus | 1 | 2009 | 36 | 0.080 |
Why?
|
| Acute Disease | 2 | 2012 | 1093 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3547 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2015 | 2307 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 250 | 0.070 |
Why?
|
| Methotrexate | 2 | 2025 | 343 | 0.070 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 97 | 0.070 |
Why?
|
| Tuberculosis | 1 | 2013 | 505 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 352 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 408 | 0.070 |
Why?
|
| Hypothyroidism | 1 | 2008 | 89 | 0.070 |
Why?
|
| Muscle Cells | 1 | 2006 | 24 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2009 | 302 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 192 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1688 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 614 | 0.070 |
Why?
|
| Necrosis | 1 | 2006 | 205 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 533 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 355 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 2055 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 1876 | 0.060 |
Why?
|
| Vinblastine | 1 | 2025 | 48 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2010 | 816 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 1236 | 0.060 |
Why?
|
| Antigens, CD1 | 1 | 2004 | 21 | 0.060 |
Why?
|
| Hodgkin Disease | 1 | 2007 | 293 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2014 | 2587 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 805 | 0.060 |
Why?
|
| Eosinophils | 2 | 2016 | 121 | 0.060 |
Why?
|
| Infant Formula | 1 | 2004 | 98 | 0.050 |
Why?
|
| Esophagus | 2 | 2016 | 214 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 1584 | 0.050 |
Why?
|
| Ethanol | 1 | 2004 | 162 | 0.050 |
Why?
|
| Prognosis | 2 | 2015 | 4512 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2021 | 16062 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 420 | 0.050 |
Why?
|
| Endoscopy | 1 | 2024 | 282 | 0.050 |
Why?
|
| HIV Infections | 1 | 2013 | 1852 | 0.050 |
Why?
|
| Biopsy | 2 | 2015 | 1236 | 0.040 |
Why?
|
| Disease Progression | 1 | 2007 | 2028 | 0.040 |
Why?
|
| Feces | 1 | 2024 | 709 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2017 | 940 | 0.040 |
Why?
|
| Skin | 2 | 2014 | 505 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 2011 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2025 | 804 | 0.040 |
Why?
|
| Young Adult | 4 | 2015 | 8864 | 0.040 |
Why?
|
| Mice | 4 | 2016 | 17542 | 0.030 |
Why?
|
| Rheumatic Diseases | 1 | 2017 | 67 | 0.030 |
Why?
|
| Janus Kinase 3 | 1 | 2016 | 16 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 1009 | 0.030 |
Why?
|
| Chloroquine | 1 | 2016 | 32 | 0.030 |
Why?
|
| Philadelphia Chromosome | 1 | 2016 | 40 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 2479 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2016 | 60 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 89 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2016 | 3722 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 50 | 0.030 |
Why?
|
| Epithelium | 1 | 2016 | 362 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2016 | 156 | 0.030 |
Why?
|
| Asperger Syndrome | 1 | 2014 | 7 | 0.030 |
Why?
|
| SMARCB1 Protein | 1 | 2014 | 37 | 0.030 |
Why?
|
| Lipomatosis | 1 | 2014 | 16 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 340 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1243 | 0.030 |
Why?
|
| Hematuria | 1 | 2014 | 53 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 464 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 426 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2013 | 118 | 0.030 |
Why?
|
| Biomarkers, Tumor | 2 | 2014 | 1439 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2013 | 81 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2013 | 238 | 0.030 |
Why?
|
| Animals | 4 | 2016 | 33798 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 528 | 0.030 |
Why?
|
| Laminectomy | 1 | 2012 | 26 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 315 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 822 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 718 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2012 | 108 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 2012 | 107 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 1003 | 0.020 |
Why?
|
| Infliximab | 1 | 2011 | 66 | 0.020 |
Why?
|
| Eyelid Diseases | 1 | 2011 | 67 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 795 | 0.020 |
Why?
|
| Oculomotor Muscles | 1 | 2011 | 63 | 0.020 |
Why?
|
| Aged | 1 | 2008 | 19108 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2010 | 32 | 0.020 |
Why?
|
| Edema | 1 | 2011 | 136 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 781 | 0.020 |
Why?
|
| Consanguinity | 1 | 2010 | 104 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 98 | 0.020 |
Why?
|
| Mutation | 2 | 2016 | 5767 | 0.020 |
Why?
|
| Adult | 3 | 2015 | 29032 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2113 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2010 | 147 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3291 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2016 | 1522 | 0.020 |
Why?
|
| Homozygote | 1 | 2010 | 532 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1118 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 962 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 1139 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1232 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 1115 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 1082 | 0.020 |
Why?
|
| United States | 2 | 2013 | 10660 | 0.020 |
Why?
|
| Pedigree | 1 | 2010 | 1576 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2011 | 808 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 2695 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 3091 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 1660 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 859 | 0.010 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 702 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3867 | 0.010 |
Why?
|
| DNA | 1 | 2010 | 1588 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 4357 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 1237 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 1213 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2056 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5040 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 4288 | 0.010 |
Why?
|
| Middle Aged | 2 | 2015 | 26015 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4226 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 12142 | 0.010 |
Why?
|